Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Molecular Biosciences|March 28, 2024
An <i>in vitro</i> analysis of an innovative standardized phospholipid carrier-based <i>Melissa officinalis</i> L<i>.</i> extract as a potential neuromodulator for emotional distress and related conditionsMehtap Kara, Sumeyye Sahin, Fazle Rabbani, et al.
International Journal of General Medicine|July 1, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
Life (Basel, Switzerland)|November 27, 2024
Assessment of Perceived Effort Through On-Field Hydration Monitoring: A Case AnalysisAlexander Bertuccioli, Roberto Cannataro, Davide Sisti, et al.
Nutrition Reviews|June 2, 2026
Ketogenic Diets and Low Carb Diets: The Effects on the Intestinal Microbiota. A Narrative ReviewAlexander Bertuccioli, Davide Sisti, Chiara Maria Palazzi, et al.
Minerva Pediatrics|June 9, 2020
Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB-12 and Enterococcus faecium L3 as prophylaxis to reduce the incidence of acute gastroenteritis and upper respiratory tract infections in childrenFrancesco DI Pierro, Patrizia Lo Russo, Maria L Danza, et al.
Frontiers in Nutrition|December 24, 2025
Study to evaluate the safety and tolerability of <i>Streptococcus salivarius</i> eK12, a genetically modified strain derived from the oral probiotic S. <i>salivarius</i> K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trialFrancesco Di Pierro, Ali Akbar Bugti, Aasiya Bano, et al.
Probiotics and Antimicrobial Proteins|April 16, 2025
Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor FecesFrancesco Di Pierro, Valeria Sagheddu, Serena Galletti, et al.
Frontiers in Pharmacology|January 30, 2023
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.
Microorganisms|June 27, 2024
Effect of <i>Bifidobacterium bifidum</i> Supplementation in Newborns Born from Cesarean Section on Atopy, Respiratory Tract Infections, and Dyspeptic Syndromes: A Multicenter, Randomized, and Controlled Clinical TrialAnna Rita Bellomo, Giulia Rotondi, Prudenza Rago, et al.
Microorganisms|September 11, 2025
RETRACTED: Bellomo et al. Effect of <i>Bifidobacterium bifidum</i> Supplementation in Newborns Born from Cesarean Section on Atopy, Respiratory Tract Infections, and Dyspeptic Syndromes: A Multicenter, Randomized, and Controlled Clinical Trial. <i>Microorganisms</i> 2024, <i>12</i>, 1093Anna Rita Bellomo, Giulia Rotondi, Prudenza Rago, et al.
Pageof 13